Lamivudine for treating active hepatitis B in renal transplant recipients: A case report

Clinical Nephrology

Volumn 53, Issue 4, 2000, Pages 44-46

  Manani, S Milan ^a   Fabbian, F ^a   Catalano, C ^a   Bordin, V ^a   Vogel, W ^b   Di Landro, D ^a  

^a Ospedale di Monselice   (Italy)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Chronic hepatitis B; Famciclovir; Lamivudine; Liver transplantation; Renal transplantation

Indexed keywords

FAMCICLOVIR; LAMIVUDINE;

ADULT; CASE REPORT; CHRONIC HEPATITIS; CONFERENCE PAPER; DRUG SAFETY; HEPATITIS B; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PREVALENCE; VIRUS REPLICATION;

HEPATITIS B; HUMANS; KIDNEY TRANSPLANTATION; LAMIVUDINE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0034115677     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Chavama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, Miyano Y et al 1998 Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 27: 1711-1716
2. Fornarion S, Pol S, Legendre C, Carnot F, Mamzer-Bruneel M-F, Brechot C, Kreis H 1996 The long-term virologie and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 62: 297-299
3. Coffin E, Horsmans Y, Cornu C, Squifflet J-P, Pirson Y 1998 Lamivudine inhibits hepatitis B virus replication in kidney graft recipient. Transplantation 66: 407-409
4. Jung YO, Lee YS, Yang S, Han DDJ, Park S-K 1998 Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. Transplantation 66: 733-737
5. Lai C-L, Chien R-N, Leung NWY, Chang T-T, Guan R, Tai D-I et al 1998 One-year trial of lamivudine for chronic hepatitis B. N Engl J Med 339: 61-68
6. Lentino JR, Leehey DJ 1994 Infections. In: Daugirdas JT, Ing TS (eds) 1994 Handbook of Dialysis (second edition). Little, Brown and Company, Boston 469-490
7. Ling R, Mittimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ 1996 Selection of mutations in hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24: 711-713
8. Melegari M, Scaglioni PP, Wands JR 1998 Hepatitis B virus mutants associated with 3TC and famiciclovir administration are replication defective. Hepatology 27: 628-633
9. Rostaing L, Henry S, Cistyrne J-M, Duffaut M, Icart J, Durand D 1997 Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. Transplantation 64: 1624-1627